These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
362 related items for PubMed ID: 981283
1. The relative importance of dopamine and noradrenaline receptor stimulation for the restoration of motor activity in reserpine or alpha-methyl-p-tyrosine pre-treated mice. Dolphin AC, Jenner P, Marsden CD. Pharmacol Biochem Behav; 1976 Jun; 4(6):661-70. PubMed ID: 981283 [Abstract] [Full Text] [Related]
2. Noradrenaline synthesis from L-DOPA in rodents and its relationship to motor activity. Dolphin A, Jenner P, Marsden CD. Pharmacol Biochem Behav; 1976 Oct; 5(4):431-9. PubMed ID: 1005491 [Abstract] [Full Text] [Related]
5. The influence of piribedil (ET495) on components of locomotor activity. Jenner P, Marsden CD. Eur J Pharmacol; 1975 Aug 29; 33(1):211-5. PubMed ID: 1175688 [Abstract] [Full Text] [Related]
6. Catecholamine receptor agonists: effects on motor activity and rate of tyrosine hydroxylation in mouse brain. Strömbom U. Naunyn Schmiedebergs Arch Pharmacol; 1976 Aug 29; 292(2):167-76. PubMed ID: 181681 [Abstract] [Full Text] [Related]
7. Bromocriptine potentiates the behavioural effects of directly and indirectly acting dopamine receptor agonists in mice. Jenkins OF, Jackson DM. Naunyn Schmiedebergs Arch Pharmacol; 1985 Oct 29; 331(1):7-11. PubMed ID: 3877878 [Abstract] [Full Text] [Related]
8. Beta-phenylethylamine and locomotor activity in mice. Interaction with catecholaminergic neurones and receptors. Jackson DM. Arzneimittelforschung; 1975 Apr 29; 25(4):622-6. PubMed ID: 168908 [Abstract] [Full Text] [Related]
10. On the role of the central noradrenergic and dopaminergic systems in the regulation of TSH secretion in the rat. Krulich L, Giachetti A, Marchlewska-Koj A, Hefco E, Jameson HE. Endocrinology; 1977 Feb 29; 100(2):496-505. PubMed ID: 188629 [Abstract] [Full Text] [Related]
12. Modification of the L-DOPA reversal of reserpine akinesia by inhibitors of dopamine-beta-hydroxylase. Dolphin A, Jenner P, Marsden CD. Eur J Pharmacol; 1976 Jan 29; 35(1):135-44. PubMed ID: 1253815 [Abstract] [Full Text] [Related]
14. Proceedings: The mechanism of the effect of dopamine-beta-hydroxylase inhibitor FLA-63 on the L-DOPA reversal of reserpine akinesia. Dolphin A, Jenner P, Marsden CD. Br J Pharmacol; 1975 Jun 29; 54(2):246P-247P. PubMed ID: 1148534 [No Abstract] [Full Text] [Related]
15. Noradrenaline but not dopamine involved in NMDA receptor-mediated hyperalgesia induced by theophylline in awake rats. Paalzow GH. Eur J Pharmacol; 1994 Jan 24; 252(1):87-97. PubMed ID: 7908645 [Abstract] [Full Text] [Related]
16. Stimulant properties of bromocriptine on central dopamine receptors in comparison to apomorphine, (+)-amphetamine and L-DOPA. Johnson AM, Loew DM, Vigouret JM. Br J Pharmacol; 1976 Jan 24; 56(1):59-68. PubMed ID: 943193 [Abstract] [Full Text] [Related]
17. The demonstration of a change in adrenergic receptor sensitivity in the central nervous system of mice after withdrawal from long-term treatment with haloperidol. Dunstan R, Jackson DM. Psychopharmacology (Berl); 1976 Jul 09; 48(1):105-14. PubMed ID: 9656 [Abstract] [Full Text] [Related]
18. Locomotor hyperactivity induced by MK-801 in rats. Maj J, Rogóz Z, Skuza G. Pol J Pharmacol Pharm; 1991 Jul 09; 43(6):449-58. PubMed ID: 1687944 [Abstract] [Full Text] [Related]
19. Endogenous dopaminergic tone and dopamine agonist action. Treseder SA, Smith LA, Jenner P. Mov Disord; 2000 Sep 09; 15(5):804-12. PubMed ID: 11009183 [Abstract] [Full Text] [Related]
20. Further studies on the interaction between bromocriptine and SKF38393 in reserpine and alpha methyl-para-tyrosine-treated mice. Jackson DM, Ross SB, Hashizume M. Psychopharmacology (Berl); 1988 Sep 09; 94(3):321-7. PubMed ID: 2895938 [Abstract] [Full Text] [Related] Page: [Next] [New Search]